Auscann Group Holdings (AC8) Short Interest
Auscann Group Holdings (ASX:AC8) had 0.01% of shares reported as short positions as of 21 Feb 2022, representing 50,867 shares. Auscann Group Holdings operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Auscann Group Holdings
AusCann Group Holdings Ltd focuses on the cultivation, manufacture, and supply of medical cannabis products. The company aims to provide high-quality, standardized cannabis-based medicines to improve patient outcomes. With a focus on research and development, AusCann seeks to establish itself as a leader in the Australian medical cannabis market.
Short position
Auscann Group Holdings (ASX:AC8) has 0.01% of its shares on issue reported as short positions as of 21 Feb 2022, or about 50,867 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.44% in January 2018. AC8 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AC8 intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of AUSCANN GROUP HOLDINGS LTD
About
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss AC8
Start a research thread or post the first pulse update